课题基金 / 基金详情

Dynamic Expression Profiling in the Intact Human Heart

Dynamic Expression Profiling in the Intact Human Heart
完整人类心脏的动态表达分析
批准号:
6536026
负责人:
MICHAEL R. BRISTOW
金额:
$15.1万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-07-01 至 2004-06-30

项目摘要

项目成果

MICHAEL R. BRISTOW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The mechanisms responsible for progressive myocardial dysfunction and remodeling of the cardiomyopathic, failing human heart are unknown. In general, these pathophysiologic mechanisms are likely to involve alterations in myocardial gene expression. Numerous recent studies have demonstrated that, in order to be meaningful, gene regulation and expression must be examined in the intact heart. The overall objective of this proposal is to investigate, in human subjects with myocardial failure from a dilated cardiomyopathy phenotype, the utility of gene expression profiling performed longitudinally as phenotype is dynamically modulated. We propose that "dynamic expression profiling" can identify gene categories as well as specific individual novel genes whose altered expression is potentially causally related to phenotypic improvement. The proposal tests one general hypothesis supported by preliminary data: that "improvement in the dilated cardiomyopathy phenotype is associated with an increase in metabolic category gene expression, and a decrease in expression within cytoskeletal, extracellular matrix, signal transduction, growth factors, transcription /translation/nucleotide synthesis, and cell cycle/apoptosis gene categories." Three Specific Aims in the proposal deal respectively with identification of categories of genes, individual genes, and kinetics of gene changes associated with phenotypic improvement in idiopathic dilated cardiomyopathy in response to 0-blocking agents. A 4th Aim compares mRNA quantitation between the Affymetrix GeneChip method and quantitative RT-PCR, for 38 genes. We have developed techniques to measure the expression of a large number of target genes in small quantities of human ventricular myocardium that can be obtained serially from the intact heart by right ventricular (RV) endomyocardial biopsy, using Affymetrix GeneChips and quantitative RT-QPCR. We have demonstrated that RT-QPCR used in a serial, longitudinal fashion is able to identify genes whose altered expression is a potential explanation for contractile dysfunction and chamber/myocyte remodeling. We have also demonstrated the utility of expression profiling in serial, longitudinal studies where phenotype is modulated by treatment, and we provide evidence that this approach is superior to "static" expression profiling performed within the context of a cross-sectional design.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7719425
  • 项目类别:
  • 资助金额:
    $0.12万
  • 财政年份:
    2008
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7604375
  • 项目类别:
  • 资助金额:
    $1.01万
  • 财政年份:
    2007
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7377772
  • 项目类别:
  • 资助金额:
    $2.69万
  • 财政年份:
    2006
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7200533
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    2005
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
海外基金